Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 129

Results For "bio"

3887 News Found

Union Health Secretary reviews Swachhata Pakhwada at AIIMS Mangalagiri
Policy | April 10, 2026

Union Health Secretary reviews Swachhata Pakhwada at AIIMS Mangalagiri

Punya Salila Srivastava commends sanitation, waste management and infection control measures, while inaugurating a new G+9 undergraduate girls’ hostel


Lupin scores major US breakthrough with FDA nod for key diabetes drug
Drug Approval | April 10, 2026

Lupin scores major US breakthrough with FDA nod for key diabetes drug

The Abbreviated New Drug Application with FDA covers multiple strengths of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets


Chiba University study flags allergy risk in high-binding antibody drugs
Biopharma | April 09, 2026

Chiba University study flags allergy risk in high-binding antibody drugs

For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms


India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters
Drug Approval | April 09, 2026

India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters

In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga


Neuberg Diagnostics unveils Neubee to make preventive healthcare simpler
Healthcare | April 09, 2026

Neuberg Diagnostics unveils Neubee to make preventive healthcare simpler

New digital health companion uses friendly, jargon-free communication to help users better understand reports


India Pharma Conference 2026 to spotlight innovation, global partnerships in New Delhi
Policy | April 09, 2026

India Pharma Conference 2026 to spotlight innovation, global partnerships in New Delhi

Discussions are likely to centre on how the country can move up the pharmaceutical value chain


Glenmark gets USFDA approval for generic Endometrin vaginal inserts
Drug Approval | April 09, 2026

Glenmark gets USFDA approval for generic Endometrin vaginal inserts

Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million


University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders
Hospitals | April 09, 2026

University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders

Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust


Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio
Biotech | April 09, 2026

Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio

The acquisition complements Gilead’s existing oncology expertise and development infrastructure


Halozyme strikes global deal with Vertex to expand Hypercon drug delivery technology
Technology | April 09, 2026

Halozyme strikes global deal with Vertex to expand Hypercon drug delivery technology

The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets